“…Our previous studies have revealed that dipeptides and phenolics—which exhibited various pharmacological activities—are the main active ingredients of this drug [ 5 ]. As part of our continuous work on the systematic study of this insect, the chemical constituents of B. rynchopetera was investigated to afford five new phenolic compounds rynchopeterines A–E ( 1 – 5 ) ( Figure 1 ), along with thirteen known phenolics, procatechuic acid ( 6 ) [ 6 ], 3,4-dihydroxyphenylacetic acid ( 7 ) [ 7 ], 3,4-dihydroxybenzaldehyde ( 8 ) [ 8 ], 3,4-dihydroxyphenylacetaldehyde ( 9 ) [ 9 ], methyl 3,4-dihydroxybenzoate ( 10 ) [ 10 ], 3,4-dihydroxyphenylacetic acid methyl ester ( 11 ) [ 11 ], 3,4-dihydroxyphenylacetic acid ethyl ester ( 12 ) [ 7 ], 2-(3,4-dihydroxyphenyl)ethanol ( 13 ) [ 12 ], 3,4-dihydroxyphenethylacetate ( 14 ) [ 13 ], blapsins A ( 15 ) and B ( 16 ) [ 14 ], 1-(3,4-dimethoxyphenyl)-4-hydroxypentan-1-one ( 17 ) [ 15 ], and 3,3′,4,4′-tetrahydroxybiphenyl ( 18 ) [ 16 ] (see Supplementary ). Herein, the isolation, structural elucidation, and bioactivity of the new compounds are described.…”